The survival period of Indocyte Carcinoma without spreading is usually 2 to 3 years, but Indocyte Carcinoma with high malignant degree is especially prone to spreading, and once spreading and metastasis occurs, its survival period is usually only 3 to 6 months. Indocyte carcinoma refers to cancer cells with abundant cytoplasm, which is full of mucus and squeezes the nucleus to the other side of the cytoplasm like a ring, so it is called indocyte carcinoma. Indocyte carcinoma is a kind of secretory adenocarcinoma, and the most common one is gastric indocyte carcinoma, which is highly malignant, prone to metastatic infiltration and has a poor prognosis. Early stage of Indocyte carcinoma can be treated by surgical resection, but the clinical symptoms of Indocyte carcinoma are not obvious in early stage, and it is usually found in advanced stage, that is, metastasis has already occurred. For advanced stage of Indocyte cancer, radiotherapy, chemotherapy and other auxiliary treatments can only be adopted, but Indocyte cancer is not sensitive to radiotherapy and chemotherapy, so the treatment effect is poor. Once diagnosed, Indocyte carcinoma should be treated immediately. If detected early and treated actively to reduce metastasis and recurrence, the survival period of patients can be prolonged to several years. Therefore, early detection, early diagnosis and early treatment are necessary for Indocyte cancer, and patients should actively cooperate with doctors for regular treatment and keep optimistic attitude to avoid the progress of the disease.